☆ 4.4 Article

Cost Effectiveness of Rituximab for Non-Hodgkinʼs Lymphoma

PHARMACOECONOMICS (2012)

Journal

PHARMACOECONOMICS

Volume 30, Issue 7, Pages 537-549

Publisher

Springer Nature

DOI: 10.2165/11591160-000000000-00000

Keywords

-

Categories

Economics

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.